Vimarsana
Biggest News Aggregation in the World

Page 3 - Gland Dysfunction News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gland Dysfunction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gland Dysfunction Today - Breaking & Trending Today

Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction - Vimarsana News

Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction

/PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), and...

Dry Eye Syndrome Treatment Market is expected to exhibit an impressive CAGR of 7% over the forecast period (2020-2030) - Vimarsana News

Dry Eye Syndrome Treatment Market is expected to exhibit an impressive CAGR of 7% over the forecast period (2020-2030)

Share this article Share this article NEW YORK, March 16, 2021 /PRNewswire/ -- Dry eye syndrome results in irritated and burning eyes due to lack of tear production and moisturization. Meibomian Gland Dysfunction has more prevalence among the geriatric population. The market consists of several products used in therapeutics, such as cyclosporine, topical corticosteroids, punctal plugs, omega supplements, and the especially popular artificial tears. Fast approval and launch of products used for dry eye treatment is expected to drive market growth in future. Several key market players are focus...